Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism
Version of Record online: 6 JUN 2011
© 2011 International Society on Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis
Volume 9, Issue 6, pages 1133–1142, June 2011
How to Cite
HEIT, J. A., CUNNINGHAM, J. M., PETTERSON, T. M., ARMASU, S. M., RIDER, D. N. and DE ANDRADE, M. (2011), Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism. Journal of Thrombosis and Haemostasis, 9: 1133–1142. doi: 10.1111/j.1538-7836.2011.04272.x
- Issue online: 6 JUN 2011
- Version of Record online: 6 JUN 2011
- Accepted manuscript online: 4 APR 2011 10:13AM EST
- Received 3 January 2011, accepted 24 March 2011
Figure S1. Comparative proteome network assembled by Ingenuity Pathways Analysis.
Table S1. List of primers used for real time PCR analysis.
|JTH_4272_sm_Supplemental-Figures1-2.doc||442K||Supporting info item|
|JTH_4272_sm_Supplement-Table-1.xls||162K||Supporting info item|
|JTH_4272_sm_Supplemental-Table-2.doc||63K||Supporting info item|
|JTH_4272_sm_Supplemental-Table-3.doc||66K||Supporting info item|
|JTH_4272_sm_Supplemental-Table-4.doc||49K||Supporting info item|
|JTH_4272_sm_Supplemental-Table-5.doc||63K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.